GGrantIndex
Sort

130,381 grants matching hiv

Natural Products Discovery and Characterization Through Network Collaborations

$1,285,542
James McMahon · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

International Studies of the Acquired Immune Deficiency Syndrome (AIDS)

$1,285,490
Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Health disparities, stress pathways, and stress-related comorbidities among MSM living with HIV

$1,285,395
Carl A Latkin · Johns Hopkins University · R01 · FY2022 · MD

Enhancing durability of V3 glycan vaccine responses in rhesus macaques

$1,285,304
Jon Steichen · Scripps Research Institute, The · R01 · FY2025 · AI

ITEST: Innovative Tools to Expand Youth-Friendly HIV Self-Testing

$1,285,153
Juliet Iwelunmor · Saint Louis University · UH3 · FY2022 · HD

Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.

$1,285,073
Mattia Bonsignori · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Progress Report for Neurotherapeutics Unit

$1,285,001
Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIC · FY2025 · NS

HIV/STD Risk Reduction For African American Couples

$1,284,997
John Barton Jemmott · University Of Pennsylvania · U10 · FY2006 · MH

SHARE Program: Innovations in Translational Behavioral Science to Improve Self-management of HIV and Alcohol Reaching Emerging adults

$1,284,974
Sylvie Naar-King · Florida State University · P01 · FY2023 · AA

Seattle-Lausanne-Kampala CTU

$1,284,773
Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2017 · AI

Molecular Studies on HIV Envelope for Vaccine Design

$1,284,298
Dennis R. Burton · Maxygen, Inc. · P01 · FY2007 · AI

HIV PREVENTION PROJECTS

$1,284,241
Sandra Klocke · Nebraska State Dept Of Health · U62 · FY2006 · PS

Chicago Clinical Trials Unit

$1,284,164
Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2021 · AI

TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGS

$1,283,804
University Of California San Francisco · P50 · FY2003 · DA

Gene Therapy Approaches for Primary Immunodeficiencies

$1,283,652
Fabio Candotti · National Human Genome Research Institute · Z01 · FY2008 · HG

National HIV Surveillance System

$1,283,509
Tom Jaenicke · Washington State Department Of Health · U62 · FY2013 · PS

GENDER EFFECTS ON HIV BIOLOGY

$1,283,479
J. David Gladstone Institutes · P01 · FY2005 · HD

Anti-HIV-1 Composite Cellulose Acetate Phthalate Film

$1,283,308
Shibo Jiang · New York Blood Center · U19 · FY2007 · AI

Anti-HIV-1 Composite Cellulose Acetate Phthalate Film

$1,283,301
New York Blood Center · U19 · FY2005 · HD

Preclinical Studies and Mucosal Responses

$1,283,173
Rama Rao Amara · Geovax, Inc. · U19 · FY2010 · AI

Vaccine and Treatment Evaluation Units

$1,282,926
Nadine Georges Rouphael · Emory University · UM1 · FY2025 · AI

Combatting drug resistance in HIV Protease: A structural Approach

$1,282,788
Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · GM

Crosstalk Among Oral & Gastrointestinal Soluble Innate Factors, HIV, & Microbes

$1,282,604
Daniel Malamud · New York University · U19 · FY2009 · DE

PS04-012, HIV PREVENTION PROJECTS

$1,282,566
Laurie Kops · Montana St Dept Of Hlth & Envrnmtl Scis · U62 · FY2008 · PS

Technology-based Treatmentsfor Substance Use Disorders

$1,282,410
Lisa A Marsch · Dartmouth College · P30 · FY2016 · DA